The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Mitochondrial DNA genetic variants are associated with systemic lupus erythematosus susceptibility, glucocorticoids efficacy and prognosis
Abstract
Objective: To investigate the associations of mitochondrial DNA (mtDNA) genetic variants with SLE susceptibility, glucocorticoid (GC) efficacy and prognosis. Methods: Our study was done in two stages. First, we performed whole mitochondrial genome sequencing in 100 patients and 100 controls to initially screen potential mtDNA variants associated with disease and GC efficacy. Then, we validated the results in an independent set of samples. In total, 605 SLE patients and 604 normal controls were included in our two-stage study. A two-stage efficacy study was conducted in 512 patients treated with GCs for 12 weeks. We also explored the association between mtDNA variants and SLE prognosis. Results: In the combined sample, four mtDNA variants (A4833G, T5108C, G14569A, CA514-515-) were associated with SLE susceptibility (all PBH < 0.05). We confirmed that T16362C was related to efficacy of GCs (PBH = 0.014). Significant associations were detected between T16362C and T16519C and the efficacy of GCs in females with SLE (PBH < 0.05). In the prognosis study, variants A4833G (PBH = 0.003) and G14569A (PBH = 9.744 × 10−4) substantially increased SLE relapse risk. Female patients harbouring variants T5108C and T16362C were more prone to relapse (PBH < 0.05). Haplotype analysis showed that haplogroup G was linked with SLE susceptibility (PBH = 0.001) and prognosis (PBH = 0.013). Moreover, mtDNA variant–environment interactions were observed. Conclusion: We identified novel mtDNA genetic variants that were associated with SLE susceptibility, GC efficacy, and prognosis. Interactions between mtDNA variants and environmental factors were related to SLE risk and GC efficacy. Our findings provide important information for future understanding of the occurrence and development of SLE.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, specific mutations in the mitochondrial genome seem geographically or ethnically restricted and thus might be grouped (that is, into haplogroups) to reveal subgroups at increased risks of developing SLE271,272.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [272]
Citations
Cites
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,905
How To Build and Interpret a Nomogram for Cancer Prognosis
Iasonos, A., Schrag, D., Raj, G. V., & Panageas, K. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.9791 · Cited by 3,222
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049
Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation
van Oven, M., & Kayser, M. (2009) · Human Mutation · doi:10.1002/humu.20921 · Cited by 1,810
Mitochondria are the powerhouses of immunity
Mills, E. L., Kelly, B., & O'Neill, L. A. J. (2017) · Nature Immunology · doi:10.1038/ni.3704 · Cited by 1,161
Mitochondrial DNA in innate immune responses and inflammatory pathology
West, A. P., & Shadel, G. S. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.21 · Cited by 1,115
Glucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983
Management strategies and future directions for systemic lupus erythematosus in adults
Durcan, L., O'Dwyer, T., & Petri, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30237-5 · Cited by 648
Coutant, C., Olivier, C., Lambaudie, E., Fondrinier, E., Marchal, F., Guillemin, F., Seince, N., Thomas, V., Levêque, J., Barranger, E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.7418 · Cited by 259
Cited by
The role of mitochondria in rheumatic diseases
Becker, Y. L. C., Duvvuri, B., Fortin, P. R., Lood, C., & Boilard, E. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00834-z · Cited by 81
Role of mitochondrial dysfunction in kidney disease: Insights from the cGAS-STING signaling pathway
Li, L., Liu, F., Feng, C., Chen, Z., Zhang, N., & Mao, J. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003022 · Cited by 32
Li, Z., Zong, Q.-Q., Zhai, C.-X., Yu, G.-H., Hu, W.-Q., Wang, Y., Wang, L., Yan, Z., Zhang, T., Teng, Y., et al. (2022) · Immunologic Research · doi:10.1007/s12026-022-09318-4 · Cited by 5
Self-citationHuang, F., Sun, K., Diao, L., Lu, K., Fan, Y., & Xie, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1928003 · Cited by 2
Udar, V., Atilano, S. R., Stephens, A. V., Chang, R. Y.-S., JACKSON, N. J., Chang, S., Chwa, M., & McCurdy, D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm15010086 · Cited by 1
Metadata
- Authors
- Teng, Y., Yan, Z.-Y., Wang, L.-L., Wang, Y.-H., Zhang, T.-Y., Li, Z., Liu, S., Cai, J., Chen, Y.-F., Li, M., Liu, S.-X., Xu, Z.-Z., Huang, H.-L., Wang, F., Pan, F.-M., Pan, H.-F., Su, H., & Zou, Y.-F.
- Affiliations
- Anhui Medical University (CN)
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University
- First Affiliated Hospital of Anhui Medical University (CN)
- Department of Rheumatology and Immunology
- Institute of Dermatology and Department of Dermatology, The First Affiliated Hospital of Anhui Medical University
- Second Affiliated Hospital of Anhui Medical University (CN)
- ORCID
- Venue
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-10-29
- Volume
- 61
- Issue
- 6
- Pages
- 2652-2662
- ISSN
- 1462-0324 (ISSN-L)
- 1462-0332
- OpenAlex
- W3209476110
- Cited by
- 5
- References
- 41
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2022: 2
- FWCI
- 0.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Lara D. Veeken (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81872683, 81673254, 81872687)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- systemic lupus erythematosus, mitochondrial DNA variants, genetic susceptibility, disease prognosis, mitochondrial haplotypes, sex differences
- MeSH terms
- DNA, Mitochondrial, Female, Glucocorticoids, Humans, Lupus Erythematosus, Systemic, Prognosis, Recurrence, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mitochondrial DNA genetic variants are associated with systemic lupus erythematosus susceptibility, glucocorticoids efficacy and prognosis. https://app.cochat.ai/papers/10.1093/rheumatology/keab806
- The paper
- Teng, Y., Yan, Z.-Y., Wang, L.-L., Wang, Y.-H., Zhang, T.-Y., Li, Z., Liu, S., Cai, J., Chen, Y.-F., Li, M., Liu, S.-X., Xu, Z.-Z., Huang, H.-L., Wang, F., Pan, F.-M., Pan, H.-F., Su, H., & Zou, Y.-F. (2022). Mitochondrial DNA genetic variants are associated with systemic lupus erythematosus susceptibility, glucocorticoids efficacy and prognosis. Rheumatology. https://doi.org/10.1093/rheumatology/keab806
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.